NCT07170150View on ClinicalTrials.gov

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

October 27, 2025

Primary Completion Date

July 25, 2028

Study Completion Date

November 7, 2028

Conditions
Alzheimers Disease
Interventions
DRUG

Trontinemab

Participants will receive IV trontinemab

OTHER

Placebo

Participants will receive IV placebo

Trial Locations (6)

32803

RECRUITING

Charter Research - Winter Park/Orlando, Orlando

90804

RECRUITING

Healthy Brain Clinic, Long Beach

V1Y 1Z9

RECRUITING

Okanagan Clinical Trials, Kelowna

710-0813

RECRUITING

Rijikai Medical Corporation Katayama Medical Clinic, Okayama

B16 8QQ

RECRUITING

Re:Cognition Health Birmingham, Birmingham

SO16 6YD

RECRUITING

Southampton University Hospitals NHS Trust, Southampton

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY